AMPLY
To add a bio or update company history, please click update information.
News from AMPLY
AMPLY
11 Feb 2026
AMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution
AMPLY Discovery applies AI to identify and validate new oncology drug targets. It combines computational analysis with laboratory testing to generate therapeutic programmes for partnering.
AMPLY
1 May 2025
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.
AMPLY
- Life Sciences
- Belfast, United Kingdom
- amplydiscovery.com
- Update Information
More venture news
- 25 Jun 2026
RQ BioRQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
Series ALife Sciences - 23 Jun 2026
TRIMTECH TherapeuticsTRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases
ExtensionLife Sciences - 19 Jun 2026
Houdini BioHoudini Bio launches with a £1.5m pre-seed led by SCVC to tackle gene silencing with machine learning DNA design platform
Pre-seedLife Sciences
